Table of Contents Author Guidelines Submit a Manuscript
International Journal of Rheumatology
Volume 2017, Article ID 9614241, 15 pages
https://doi.org/10.1155/2017/9614241
Review Article

Review of Routine Laboratory Monitoring for Patients with Rheumatoid Arthritis Receiving Biologic or Nonbiologic DMARDs

1Geisel School of Medicine, Dartmouth College, Lebanon, NH, USA
2Ultragenyx Pharmaceutical, Inc., Novato, CA, USA
3Genentech, Inc., South San Francisco, CA, USA
4Division of Rheumatology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA
5University of Washington, Seattle, WA, USA
6University of Florence, Florence, Italy

Correspondence should be addressed to William F. C. Rigby; ude.htuomtrad@ybgir.mailliw

Received 16 February 2017; Accepted 15 August 2017; Published 31 October 2017

Academic Editor: Ruben Burgos-Vargas

Copyright © 2017 William F. C. Rigby et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [3 citations]

The following is the list of published articles that have cited the current article.

  • Yu. V. Muravyev, and L. A. Muravyeva, “The problem of laboratory monitoring in therapy with disease-modifying antirheumatic drugs and biological agents in patients with rheumatoid arthritis,” Modern Rheumatology Journal, vol. 12, no. 3, pp. 120–123, 2018. View at Publisher · View at Google Scholar
  • Biljana Radovanović-Dinić, Snežana Tešić-Rajković, Valentina Zivkovic, and Saša Grgov, “Clinical connection between rheumatoid arthritis and liver damage,” Rheumatology International, 2018. View at Publisher · View at Google Scholar
  • Kimberly N. Weaver, and Millie D. Long, “Preventive Medicine in Inflammatory Bowel Disease,” Clinical Gastroenterology and Hepatology, 2018. View at Publisher · View at Google Scholar